# NK-One Therapeutics, Inc. — Form D

NK-One Therapeutics, Inc. of WAYNE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-27. The offering totals $310K, of which $290K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-04-27
- Form: D
- Accession: 0002127553-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $310K
- Amount sold: $290K
- Remaining: $20K
- Investors: 7
- Revenue range: Decline to Disclose
- SEC file number: 021-581982

## Issuer

- Name: NK-One Therapeutics, Inc.
- CIK: 0002127553
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 526 PARK RIDGE DRIVE, WAYNE, PA, 19087
- Phone: 610-733-0446

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Marco Pappagallo | Related Person | Wayne, PA |
| Michael Shine | Related Person | Wayne, PA |

## More

- [CIK 2127553 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2127553&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002127553-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.